Company Filing History:
Years Active: 1981
Title: The Innovations of Barry Gotlinksy
Introduction
Barry Gotlinksy is an accomplished inventor based in the Bronx, NY. He has made significant contributions to the field of biochemistry, particularly in the area of cholesterol biosynthesis. His work has implications for understanding and potentially treating cholesterol-related health issues.
Latest Patents
Barry Gotlinksy holds a patent for "In vivo inhibitors of cholesterol biosynthesis." This patent includes the compounds Dialkyl esters of 5-carbo[etiocholane-3'.alpha.-7'.alpha., 12'.alpha.-trihydroxy-17'.beta.(1' methyl-4' butyl]oxy-4-hydroxy-4-methylpentyl-1-phosphonate and 5-carbohexadecyloxy-4-hydroxy-4-methylpentyl-1-phosphonate. These compounds have been shown to inhibit cholesterol biosynthesis in rat liver cells, providing a foundation for further research in this critical area.
Career Highlights
Barry Gotlinksy is affiliated with the City University of New York, where he has been able to leverage his expertise in biochemistry. His research has not only contributed to academic knowledge but also has potential applications in the pharmaceutical industry.
Collaborations
Some of Barry's notable coworkers include Robert R Engel and Virender K Sarin. Their collaborative efforts have likely enhanced the research output and innovation in their respective fields.
Conclusion
Barry Gotlinksy's work exemplifies the intersection of academic research and practical application in the field of biochemistry. His patent on cholesterol biosynthesis inhibitors highlights his innovative contributions to health science.